Bank Of New York Mellon Corp Sana Biotechnology, Inc. Transaction History

Bank Of New York Mellon Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.19 - $6.46 $1.16 Million - $2.35 Million	364,157 New	364,157 $1.44 Million
Q3 2022 Nov 14, 2022	BUY	$5.58 - $9.04 $346,975 - $562,125	62,182 Added 20.09%	371,664 $2.23 Million
Q2 2022 Aug 15, 2022	SELL	$4.12 - $9.35 $189,355 - $429,726	-45,960 Reduced 12.93%	309,482 $1.99 Million
Q1 2022 May 11, 2022	SELL	$5.24 - $15.58 $7,173 - $21,329	-1,369 Reduced 0.38%	355,442 $2.94 Million
Q4 2021 Feb 11, 2022	BUY	$15.18 - $23.15 $524,210 - $799,438	34,533 Added 10.72%	356,811 $5.52 Million
Q3 2021 Nov 12, 2021	BUY	$16.29 - $25.88 $3.83 Million - $6.08 Million	234,977 Added 269.16%	322,278 $7.26 Million
Q2 2021 Aug 11, 2021	BUY	$16.65 - $32.14 $635,963 - $1.23 Million	38,196 Added 77.78%	87,301 $1.72 Million
Q1 2021 May 13, 2021	BUY	$23.04 - $43.5 $1.13 Million - $2.14 Million	49,105 New	49,105 $1.64 Million

176

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $569M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.